GE Healthcare has launched a new magnetic resonance (MR) imaging technique Mavric SL to accurately image soft tissue and bone in patients with MR Conditional-labeled implants.
Developed in collaboration with Hospital for Special Surgery and Stanford University, Mavric SL will collect multiple snapshots taken at different frequencies.
These individual snapshots are then combined to form the final image and then deblurring post-processing technique is implemented to optimize the volume combination process.
Mavric SL is expected to impact patient care providing valuable clinical information for an issue that can have significant human and economic costs, particularly when diagnosis is delayed.
Using thus obtained visual aids, the patients can clearly understand the cause for their pain with the physician’s assistance.
Mavric SL focuses on innovating standards in care and safety for patients and to improve diagnosis accuracy by delivering image quality.
Hospital for Special Surgery Attending Orthopedic Surgeon Mathias Bostrom said, "The development of the MAVRIC protocol has given us a window into the local tissue response to implants and a better understanding of the underlying cause of patients’ pain and poor function."
GE Healthcare Magnetic Resonance business unit president and CEO Richard Hausmann said that the current MR technology is limited and Mavric SL addresses this major gap in patient care.
Image: Mavric SL demonstrates evidence of an abnormal synovial response indicative of an adverse tissue reaction (arrow). Photo: Courtesy of Business Wire/GE Healthcare.